Market by Deployment Mode, Component, Product Type, End-user, and Country | Forecast 2021-2028
Triton’s
research report establishes the clinical trial management market in the Middle
East and Africa to observe growth at a compound annual growth rate of 9.55%
during the projected years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered for analysis in this market are:
• The United Arab Emirates
• Turkey
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
In
the Middle East and Africa, the increase in government funding and the
development of healthcare awareness programs are key factors motivating the
market’s growth. Additionally, as the region is an emerging market, it creates
several lucrative opportunities for players due to the rise in the number of
laboratories with advanced systems. The increase in R&D activities, along
with an upsurge in awareness pertaining to clinical trial management, are also
supplementing the studied market’s growth over the forecast period.
Over
the years, the changes in the regulatory framework in the pharmaceutical
industry have led to more influx of healthcare budgets in the UAE. Moreover,
the pharmaceutical sector has grown mainly owing to the increase in R&D
activities, along with the incorporation of more elements. This has made the
country a top destination for conducting clinical research studies. Further,
the major increase in the number of clinical studies, drug identification, and
development have extended the market’s progress. Along with this, the market
outlook for pipeline drugs is also expected to be beneficial as the developing
medicines are anticipated to generate huge returns. Thus, the pharmaceutical
sector development is estimated to support the growth of the clinical trial management
market in the UAE over the next few years.
Parexel
International Corporation is a biopharmaceutical outsourcing company. It aims
to simplify the complex development journey, including planning and
post-launch, required by biopharma and medical device companies. The company
offers clinical research & logistics, medical communication,
commercialization, and technology products to several industries. Parexel has
operations in various regions, including the Middle East and Africa region.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
SCOPE
2.2. KEY
INSIGHTS
2.2.1. ENTERPRISE-BASED
CTM CONTRIBUTES A MAJOR SHARE IN PRODUCT TYPE SEGMENT
2.2.2. HEALTHCARE
PROVIDERS ARE RAPIDLY GROWING END-USERS IN THE MARKET
2.2.3. SOFTWARE
IS THE LARGEST COMPONENT IN THE CLINICAL TRIAL MANAGEMENT MARKET
2.2.4. CLOUD
MODEL OF DEPLOYMENT IS A PROMISING SEGMENT IN THE MARKET
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. INTENSITY
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. MARKET
DRIVERS
2.6.1. ALARMING
RISE IN CHRONIC DISEASES
2.6.2. SURGE
IN RESEARCH & DEVELOPMENT IN THE MEDICAL SECTOR
2.6.3. BENEFITS
OFFERED BY CTM SOFTWARE
2.7. MARKET
RESTRAINTS
2.7.1. CONCERN
REGARDING THE SECURITY OF CTM SYSTEMS
2.7.2. LACK
OF SKILLED WORKFORCE
2.7.3. HIGH
COST OF IMPLEMENTATION
2.8. MARKET
OPPORTUNITIES
2.8.1. GROWTH
IN CLINICAL TRIALS
2.8.2. OUTSOURCING
CLINICAL TRIALS FOR COST REDUCTION
2.9. KEY
STRATEGIC DEVELOPMENTS
2.9.1. MERGER
& ACQUISITIONS
2.9.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.9.3. PARTNERSHIP,
CONTRACT/AGREEMENT, & COLLABORATION
2.10. IMPACT
OF COVID-19 ON THE CLINICAL TRIAL MANAGEMENT MARKET
3. MIDDLE
EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY DEPLOYMENT MODE
3.1. WEB-BASED
DEPLOYMENT
3.2. ON-PREMISE
DEPLOYMENT
3.3. CLOUD-BASED
DEPLOYMENT
4. MIDDLE
EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY COMPONENT
4.1. SOFTWARE
4.2. HARDWARE
4.3. SERVICES
5. MIDDLE
EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY PRODUCT TYPE
5.1. ENTERPRISE-BASED
CTM
5.2. SITE-BASED
CTM
6. MIDDLE
EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY END-USER
6.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
6.2. CLINICAL
RESEARCH ORGANIZATIONS
6.3. HEALTHCARE
PROVIDERS
7. CLINICAL
TRIAL MANAGEMENT MARKET – MIDDLE EAST AND AFRICA
7.1. UNITED
ARAB EMIRATES
7.2. TURKEY
7.3. SAUDI
ARABIA
7.4. SOUTH
AFRICA
7.5. REST
OF MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. MEDIDATA
SOLUTIONS INC
8.2. ARISGLOBAL
LLC
8.3. BIOCLINICA
INC
8.4. BIO-OPTRONICS
INC
8.5. ADVARRA
(FORTE RESEARCH SYSTEMS INC)
8.6. ORACLE
CORPORATION
8.7. IBM
CORPORATION
8.8. MEDNET
SOLUTIONS INC
8.9. PAREXEL
INTERNATIONAL CORPORATION
8.10. VEEVA
SYSTEMS INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $
MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN
$ MILLION)
TABLE 4: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $
MILLION)
TABLE 5: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $
MILLION)
TABLE 6: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY END USER, 2021-2028 (IN $
MILLION)
TABLE 7: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $
MILLION)
FIGURE 1: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2020 &
2028 (IN %)
FIGURE 2: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 3: MARKET
ATTRACTIVENESS INDEX
FIGURE 4: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2021-2028
(IN $ MILLION)
FIGURE 5: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT,
2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT,
2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2021-2028 (IN $
MILLION)
FIGURE 8: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2021-2028 (IN $
MILLION)
FIGURE 9: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2021-2028 (IN $
MILLION)
FIGURE 10: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2021-2028
(IN $ MILLION)
FIGURE 11: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2021-2028 (IN $
MILLION)
FIGURE 12: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL &
BIOPHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH
ORGANIZATIONS, 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2021-2028
(IN $ MILLION)
FIGURE 15: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028
(IN %)
FIGURE 16: UNITED ARAB
EMIRATES CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 17: TURKEY
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 18: SAUDI ARABIA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 19: SOUTH AFRICA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: REST OF
MIDDLE EAST & AFRICA CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $
MILLION)